Timothy C. Barabe - 12 Aug 2024 Form 4 Insider Report for Cartesian Therapeutics, Inc. (RNAC)

Role: Director
Signature: /s/ Matthew Bartholomae, Attorney-in-Fact for Timothy C. Barabe
Issuer symbol: RNAC
Transactions as of: 12 Aug 2024
Net transactions value: +$95,250
Form type: 4
Filing time: 14 Aug 2024, 16:41:54 UTC
Previous filing: 04 Jan 2024
Next filing: 06 Jan 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RNAC	Common Stock	Purchase	$95,250	+7,500	+53%	$12.70	21,766	12 Aug 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	RNAC	Stock Option (Right to Buy)						7,600	12 Aug 2024	Common Stock	7,600	$19.66	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On April 4, 2024, the issuer effected a 1-for-30 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 has been adjusted to reflect the Reverse Stock Split.
F2	This award will vest in 36 equal monthly installments, so that it shall be fully vested on the third anniversary of the date of grant.